HK1145343A1 - 3.4 kb mitochondrial dna deletion for use in the detection of cancer 34kb dna - Google Patents
3.4 kb mitochondrial dna deletion for use in the detection of cancer 34kb dnaInfo
- Publication number
- HK1145343A1 HK1145343A1 HK10111822.9A HK10111822A HK1145343A1 HK 1145343 A1 HK1145343 A1 HK 1145343A1 HK 10111822 A HK10111822 A HK 10111822A HK 1145343 A1 HK1145343 A1 HK 1145343A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- dna
- cancer
- detection
- deletion
- mitochondrial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CA2007/001711 WO2009039601A1 (en) | 2007-09-26 | 2007-09-26 | 3.4 kb mitochondrial dna deletion for use in the detection of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1145343A1 true HK1145343A1 (en) | 2011-04-15 |
Family
ID=40510689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK10111822.9A HK1145343A1 (en) | 2007-09-26 | 2010-12-17 | 3.4 kb mitochondrial dna deletion for use in the detection of cancer 34kb dna |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP2203570B1 (xx) |
| JP (1) | JP5518715B2 (xx) |
| KR (1) | KR101449562B1 (xx) |
| CN (1) | CN101874119B (xx) |
| AU (1) | AU2007359381B2 (xx) |
| CA (1) | CA2700941A1 (xx) |
| ES (2) | ES2484044T3 (xx) |
| HK (1) | HK1145343A1 (xx) |
| NZ (1) | NZ584815A (xx) |
| SG (1) | SG185254A1 (xx) |
| WO (1) | WO2009039601A1 (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2704361C (en) * | 2007-11-09 | 2023-04-04 | Genesis Genomics Inc. | Mitochondrial dna deletion between about residues 12317-16254 for use in the detection of cancer |
| CN107011428B (zh) | 2008-03-28 | 2022-02-25 | Mdna生命科学有限公司 | 异常线粒体dna、相关的融合转录物及其杂交探针 |
| EP3272871B1 (en) * | 2009-03-27 | 2020-01-15 | MDNA Life Sciences Inc. | Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050026167A1 (en) * | 2001-06-11 | 2005-02-03 | Mark Birch-Machin | Complete mitochondrial genome sequences as a diagnostic tool for the health sciences |
| JP2005506057A (ja) * | 2001-06-11 | 2005-03-03 | １３０４８５４ オンタリオ・リミテッド | 健康科学のための診断ツールとしての全ミトコンドリアゲノム配列 |
| CA2792443A1 (en) | 2005-04-18 | 2006-10-26 | Ryan Parr | Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
-
2007
- 2007-09-26 WO PCT/CA2007/001711 patent/WO2009039601A1/en active Application Filing
- 2007-09-26 CA CA2700941A patent/CA2700941A1/en not_active Abandoned
- 2007-09-26 KR KR1020107007603A patent/KR101449562B1/ko active IP Right Grant
- 2007-09-26 AU AU2007359381A patent/AU2007359381B2/en not_active Expired - Fee Related
- 2007-09-26 EP EP07815900.1A patent/EP2203570B1/en active Active
- 2007-09-26 EP EP13169334.3A patent/EP2634267B1/en not_active Not-in-force
- 2007-09-26 NZ NZ584815A patent/NZ584815A/en unknown
- 2007-09-26 ES ES07815900.1T patent/ES2484044T3/es active Active
- 2007-09-26 ES ES13169334.3T patent/ES2539001T3/es active Active
- 2007-09-26 SG SG2012071478A patent/SG185254A1/en unknown
- 2007-09-26 CN CN200780101671.5A patent/CN101874119B/zh active Active
- 2007-09-26 JP JP2010526114A patent/JP5518715B2/ja active Active
-
2010
- 2010-12-17 HK HK10111822.9A patent/HK1145343A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007359381B2 (en) | 2015-06-18 |
| JP5518715B2 (ja) | 2014-06-11 |
| EP2203570B1 (en) | 2014-04-23 |
| SG185254A1 (en) | 2012-11-29 |
| JP2010539908A (ja) | 2010-12-24 |
| KR101449562B1 (ko) | 2014-10-13 |
| CA2700941A1 (en) | 2009-04-02 |
| NZ584815A (en) | 2012-07-27 |
| CN101874119A (zh) | 2010-10-27 |
| EP2203570A1 (en) | 2010-07-07 |
| EP2634267B1 (en) | 2015-02-18 |
| AU2007359381A1 (en) | 2009-04-02 |
| KR20100069670A (ko) | 2010-06-24 |
| EP2203570A4 (en) | 2010-09-01 |
| ES2484044T3 (es) | 2014-08-08 |
| ES2539001T3 (es) | 2015-06-25 |
| EP2634267A1 (en) | 2013-09-04 |
| CN101874119B (zh) | 2015-01-28 |
| WO2009039601A1 (en) | 2009-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Small et al. | Meet your iBrain | |
| SI2217578T1 (sl) | (1,2,4)triazolo(1,5-a)piridinske in (1,2,4)triazolo(1,5-c)pirimidinske spojine in njihova uporaba | |
| BRPI1004572A2 (pt) | "fusões genéticas recorrentes em câncer | |
| IL198305A0 (en) | Cancer susceptibility variants on chr8q24.21 | |
| IL206127A0 (en) | Azolylmethyloxiranes, use thereof and agents containing the same | |
| HK1201182A1 (en) | Pegylated il-10 for use in treating cancer or tumor il-10 | |
| PT2101731T (pt) | Endoxifeno para utilização no tratamento de cancro | |
| HK1131922A1 (en) | Phenylpropionamide compounds and the use thereof | |
| HK1131140A1 (en) | Substituted prolinamides, and the use thereof | |
| GB0724881D0 (en) | Methods for the detection of colorectal cancer | |
| IL216723A0 (en) | 1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer | |
| GB0814212D0 (en) | Improvements in or relating to fires heating apparatus or the like | |
| ZA200808754B (en) | Tetrahydronaphthaline derivatives, methods for the production and use hereof as anti-inflammatory agents | |
| EP2167083A4 (en) | NOVEL HETEROARYL-3-AZABICYCLOÝ3.1.0HEXANES, THEIR METHODS OF PREPARATION AND THEIR USE AS MEDICAMENTS | |
| PL2235013T3 (pl) | Podstawione związki tetrahydroimidazopirydynowe i ich zastosowanie w farmaceutykach | |
| IL208168A (en) | Tetrahydroisoquinoline derivatives, preparations containing them and their use | |
| IL206189A (en) | Compounds for use in cancer treatment | |
| HK1145343A1 (en) | 3.4 kb mitochondrial dna deletion for use in the detection of cancer 34kb dna | |
| EP2220252A4 (en) | SUPPRESSION OF MITOCHONDRIAL DNA MUTATIONS BETWEEN RESIDUES 12317-16254 FOR USE IN THE DETECTION OF CANCER | |
| SG10202008082XA (en) | 3.4 kb Mitochondrial DNA Deletion for use in the Detection of Cancer | |
| SG10201600490PA (en) | 3.4 kb Mitochondrial DNA Deletion for use in the Detection of Cancer | |
| Westerhoff | Set in our Ways | |
| IL206379A0 (en) | 17-HYDROXY-19-NOR-21-CARBOXYLIC ACID-STEROID ã?-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING THE DERIVATIVE | |
| PL2288342T3 (pl) | Układ na bazie magnezu i jego zastosowanie w kosmetyce | |
| Lowitt | The employment creation potential of recycling in South Africa |